Scinai Immunotherapeutics (SCNI) Accounts Payables (2015 - 2026)
Scinai Immunotherapeutics (SCNI) posted Accounts Payables of $779000.0 for Q1 2026, up 91.4% sequentially from $407000.0 in Q4 2025.
Scinai Immunotherapeutics (SCNI) Accounts Payables (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Accounts Payables for 12 years, with the latest figure at $779000.0 in Q1 2026.
- Quarterly Accounts Payables changed N/A year-over-year to $779000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $779000.0 (changed N/A YoY) and the FY2025 annual result came in at $407000.0, down 59.54% from the prior year.
- Accounts Payables advanced to $779000.0 in Q1 2026 per SCNI's latest filing, from $407000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $1.3 million in Q1 2023 and troughed at $297000.0 in Q3 2022.
- A 5-year average of $776200.0 and a median of $659000.0 in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables sank 99.98% in 2022, then soared 83.84% in 2023.
- Over 5 years, Accounts Payables stood at $1.2 million in 2022, then tumbled by 31.53% to $849000.0 in 2023, then grew by 18.49% to $1.0 million in 2024, then plunged by 59.54% to $407000.0 in 2025, then surged by 91.4% to $779000.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $779000.0, $407000.0, and $659000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 779,000.00 |
| Dec 31, 2025 | 407,000.00 |
| Jun 30, 2025 | 659,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 430,000.00 |
| Jun 30, 2024 | 658,000.00 |
| Mar 31, 2024 | 928,000.00 |
| Dec 31, 2023 | 849,000.00 |
| Sep 30, 2023 | 546,000.00 |
| Jun 30, 2023 | 651,000.00 |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 588,000.00 |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 999,000.00 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 2.64 Bn |
| Mar 31, 2021 | 2.09 Bn |
| Dec 31, 2020 | 1.87 Bn |